3rd TRANSCAN-3 Joint Call 2023

Basic Information

Translational research on cancer epigenetics

Network TRANSCAN-3
Website https://transcan.eu/funding/calls/joint-call-jtc-2023-.kl
Aim of the joint call The expected outcome of the call is to improve the efficacy of current detection, diagnosis, prognosis and treatment of cancers, through the development of novel approaches based on a better understanding of cancer epigenetics. The specific objectives of this funding opportunity are to stimulate new partnerships between researchers and clinicians and support original, high-quality projects, with significant clinical impact.
Type of joint call Two Stages - Call with pre-proposals and full proposals submissions
Events
Launch date 09/05/2023
Deadline Pre-Proposal 21/07/2023 Submitted proposal: 83
Deadline Full-Proposal 15/12/2023 Submitted proposal: 41
Evaluation End Date 01/05/2024 Successful proposal: 13 Proposals funded: 13
Is call co-funded? Yes
Call follow up funding n/a
Call reasons n/a
Research fields
  • Health
Type of research
  • Basic research
  • Applied Research
Target groups
  • Higher Education Institutions (HEIs)
  • Public Research Organisations (PROs)
  • Private and Semi-private Research and Technology Organisations (RTOs)
  • SME (Small and Medium Enterprises)
Participating networks n/a

Organisations Participating

Country Organisation
Austria Austrian Science Fund (FWF)
Belgium National Fund for Scientific Research (FNRS)
Canada Canadian Institutes of Health Research (CIHR)
Estonia Estonian Science Foundation (ETAG)
France ARC French foundation for Cancer Research (ARC-France)
France National Cancer Institute (INCa)
Germany Federal Ministry of Education and Research (BMBF)
Hungary National Research, Development and Innovation Office (NKFIH)
Ireland Health Research Board (HRB)
Israel Ministry of Health (CSO-MOH)
Italy Ministry of Health (MOH/MDS)
Italy REGIONAL FOUNDATION FOR BIOMEDICAL RESEARCH (FRRB)
Italy Tuscany Region (TOS)
Latvia Latvian Council of Science (LCS)
Luxembourg National Fund for Research (FNR)
Norway Norwegian Cancer Society (NCS)
Norway Research Council of Norway (RCN)
Poland National Centre for Research and Development (NCBiR)
Romania Executive Agency for Higher Education, Research, Development and Innovation Funding (UEFISCDI)
Slovakia Slovak Academy of Science (SAS/SAV)
Spain Institute of Health Carlos III (ISCIII)
Spain Spanish Association Against Cancer Scientific Foundation (AECC FC)
Taiwan National Science and Technology Council / Ministry of Science and Technology (NSTC / MoST Taiwan)
Türkiye The Scientific and Technological Research Council of Turkey (TUBITAK)

Funded Projects

Acronym Title Start End No. partners
DC2M-TAEC Detection, Classification, Characterization and Treatment Mo... 01/04/2025 31/03/2028 4
DICE Epigenomic regulation of cancer immunity by dietary interven... 01/04/2025 31/03/2028 6
EPILUCAFS Chronic stress and immunosuppression in lung cancer: focus o... 01/04/2025 31/03/2028 6
EPILUNAR Epigenomic Profiling of Liquid Biopsy and Immunotherapy Resi... 01/04/2025 31/03/2028 5
EPIPROPER Identifying EPIgenetic determinants and biomarkers of drug r... 01/04/2025 31/03/2028 5
EPI_T-ALL Unveiling the Epigenetic Landscape and Therapeutic Implicati... 01/04/2025 31/03/2028 4
EXPLORE-NB Exploring the epigenetic neuroblastoma landscape to improve ... 01/04/2025 31/03/2028 6
EpiNanSarc Sarcoma subtyping and stratification using genome-wide epige... 01/04/2025 31/03/2028 7
HYDRA Charting the epigenomic trajectory of progression towards me... 01/04/2025 31/03/2028 5
REACH Reversing Epitranscriptomic Alterations for CHemosensitizati... 01/04/2025 31/03/2028 5
REACTION Deciphering Epigenetic Biomarkers to Identify Preleukemic Ca... 01/04/2025 31/03/2028 6
SCIE-PANC Stromal Compartment and Immune Epigenome spatial networks to... 01/04/2025 31/03/2028 6
SPELCASTER Standardized Profiling of Epigenetic Loci for decentralized ... 01/04/2025 31/03/2028 6